Impact of left ventricular hypertrophy late after aortic valve replacement for aortic stenosis on cardiovascular morbidity and mortality

International Journal of Cardiology

Volumn 109, Issue 1, 2006, Pages 41-47

  Zybach Benz, Renate E ^a,c   Aeschbacher, Beat C ^b   Schwerzmann, Markus ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b HerzZentrum Bern   (Switzerland)

^c NONE   (Switzerland)

Author keywords

Aortic valve stenosis; Left ventricular hypertrophy; Morbidity; Mortality; Prosthetic valve

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGED; ANAMNESIS; ANGIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MUSCLE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE MASS; PREVALENCE; PRIORITY JOURNAL; SURGICAL MORTALITY; TERTIARY HEALTH CARE; THORAX PAIN;

ADULT; AGED; AORTIC VALVE STENOSIS; FEMALE; HEART DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITALIZATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33645394150     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.050     Document Type: Article

References (29)

1. W. Grossman, D. Jones, and L.P. McLaurin Wall stress and patterns of hypertrophy in the human left ventricle J Clin Invest 56 1975 56 64
2. S. Sasayama, J. Ross, and D. Franklin Adaptations of the left ventricle to chronic pressure overload Circ Res 38 1976 172 178
3. O.M. Hess, B. Villari, and H.P. Krayenbuehl Diastolic dysfunction in aortic stenosis Circulation 87 1993 IV73 IV76
4. X.Y. Jin, J.R. Pepper, and S.J. Brecker Early changes in left ventricular function after aortic valve replacement for isolated aortic stenosis Am J Cardiol 74 1994 1142 1146
5. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study N Engl J Med 322 1990 1561 1566
6. J. Lessick, D. Mutlak, and W. Markiewicz Failure of left ventricular hypertrophy to regress after surgery for aortic valve stenosis Echocardiography 19 2002 359 366
7. D.J. Sahn, A.N. DeMaria, and J. Kisslo Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
8. B.L. Troy, J. Pombo, and C.E. Rackley Measurement of left ventricular wall thickness and mass by echocardiography Circulation 45 1972 602 611
9. R. Devereux, D.R. Alonso, and E.M. Lutas Echocardiographic assessment of left hypertrophy: comparison to necropsy findings Circulation 57 1986 450 458
10. D.D. Savage, R.J. Garrison, and W.B. Kannel The spectrum of ventricular hypertrophy in a general population sample: the Framingham study Circulation 75 1987 126 133
11. D.J. Lips, L.J. deWindt, and D.J. van Kraaij Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy Eur Heart J 24 2003 883 896
12. J. Fielitz, M. Leuschner, H.R. Zurbrügg, B. Hannack, R. Pregla, and R. Hetzer Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis J Mol Med 82 2004 809 820
13. T. Walther, A. Schubert, and V. Falk Regression of left ventricular hypertrophy after surgical therapy of aortic stenosis is associated with changes in extracellular matrix gene expression Circulation 104 2001 I54 I58
14. H.P. Kuehl, A. Franke, and D. Puschmann Regression of left ventricular mass one year after aortic valve replacement for pure severe aortic stenosis Am J Cardiol 89 2002 408 413
15. Ch. Seiler, and R. Jenni Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors, and short-term follow up after aortic valve replacement Heart 76 1996 250 255
16. I. Ikonomidis, A. Tsoukas, and F. Parthenakis Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function Heart 86 2001 309 316
17. B. Villari, G. Vassalli, and E.S. Monrad Normalization of diastolic dysfunction in aortic stenosis late after valve replacement Circulation 91 1995 2353 2358
18. D.J.R. Hildick-Smith, and L.M. Shapiro Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study J Am Coll Cardiol 36 2000 1889 1896
19. J.M. Giardian, D. Siscovick, H. Anton-Culver, V.-E. Smith, S. Klopfenstein, and W. Bommer Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health Study (CHS) Circulation 91 1995 1739 1748
20. J.M. Gardin, A. Arnold, J.S. Gottdiener, N.D. Wong, L.P. Fried, and S. Klopfenstein Left ventricular mass in the elderly. The cardiovascular health study Hypertension 29 1997 1095 1103
21. W.L. Henry, J.M. Gardin, and J.H. Ware Echocardiographic measurements in normal subjects from infancy to old age Circulation 62 1980 1054 1061
22. C. Bethge, W. Motz, A. von Hehn, and B.E. Strauer Ventricular arrhythmias in hypertensive heart disease with and without heart failure J Cardiovasc Pharmacol 10 1987 119 128
23. C. Martinez-Useros, P. Tornos, J. Montoyo, M.G. Permanyer, M. Alijarde, and H. Garcia del Castillo Ventricular arrhythmias in aortic valve disease: a further marker of impaired left ventricular function Int J Cardiol 34 1992 49 56
24. B. Dahlof, K. Pennert, and L. Hansson Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies Am J Hypertens 5 1992 95 110
25. B. Dahlof, R. Devereux, U. de Faire, F. Fyhrquist, T. Hedner, and H. Ibsen The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group Am J Hypertens 10 1997 705 713
26. D. Levy, R.J. Garrison, and D.D. Savage Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study Ann Intern Med 110 1989 101 107
27. P.N. Casale, R.B. Devereux, and M. Milner Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men Ann Intern Med 105 1986 173 178
28. S. Frank, A. Johnson, and J. Ross Natural history of valvular aortic stenosis Br Heart J 35 1973 41 46
29. D.A. Orsellini, G.P. Aurigemma, and S. Battista Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness J Am Coll Cardiol 22 1993 1679 1683